-Reuters
Barrington Research Maintains Outperform on Cross Country Healthcare, Raises Price Target to $45
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and raises the price target from $41 to $45.